Body Composition Analyzers Market Overview 2030
The global body composition analyzers market size was valued at $398.22 million in 2020, and is projected to reach $618.71 million by 2030, growing at a CAGR of 4.5% from 2021 to 2030. Body composition is a method of analyzing the body into its constituent parts such as fat, protein, minerals, and body water. Body composition analyzer (BCA) is a device that is used to measure various components in the body. A body composition analyzer efficiently analyses the weight, body mass index (BMI), and weight percentages from fat, muscle, bone, and water.
It measures weight and provides a better image of overall health than traditional methods. Furthermore, it helps in the analysis of cumulative differences in body structure over a specific time period. In addition, it used to detect the chances of developing certain ailment as skin fold measurements and abdominal obesity The global body composition analyzers market is anticipated to experience growth due to increase in obese population and increase in government initiatives to promote a healthy lifestyle Body composition analyzers include features such as total body water, protein, minerals, body fat mass, weight, skeletal muscle mass, BMI, body composition history, and obesity evaluation. . Furthermore, high equipment cost, and stringent regulatory framework regarding the use of body composition analyzers hinder the market growth.
The body composition analyzers market is segmented on the basis of on product, end-user, and region. By product, the market is categorized into bio-impedance analyzer, dual energy X-ray absorptiometry equipment, skinfold calipers, air displacement plethysmography equipment, hydrostatic weighing equipment, and others. On the basis of end user, it is fragmented into hospitals, fitness clubs & wellness centers, home users, and others. On the basis of region, it is classified into the North America, Europe, Asia-Pacific, and LAMEA.
What is the Impact of COVID-19 Pandemic on the Body Composition Analyzers Market?
Coronavirus (COVID-19) was identified in Hubei province of Wuhan city in China in December 2019. The disease is caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted among humans. After its discovery in Wuhan, the disease rapidly spread to other parts of the globe. Furthermore, this virus causes various symptoms in patients, which range from mild to severe symptoms. The mild symptoms include fever, dry cough, and fatigue. However, severe symptoms include difficulty in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement. Furthermore, the virus has a significant fatality potential in geriatric population. On March 11, 2020, the World Health Organization declared COVID-19 to be pandemic.
Only a few vaccinations have been granted emergency authorization for COVID-19 prevention. Thus, social distance is regarded as the most significant strategy for limiting the spread of this disease. Furthermore, various countries across the globe have implemented nationwide lockdowns, to follow social distancing norms and prevent the spread of the virus.
The pandemic is affecting almost every nation. Most markets are experiencing a decline, owing to the outbreak. The COVID-19 pandemic is an unprecedented public health challenge, and is anticipated to have a negative impact on the body composition analyzers market, due to lockdowns and stay-at-home orders. Furthermore, people have much more time than before. Many people drink carbo-hydrated beverages and eat non-healthy fat, due to lifestyle changes and rise in convenience of home-delivered food. These factors minimize the demand for body composition analyzers for monitoring health during lockdowns.
Product Type Segment Review
By product type, the market is divided into bio-impedance analyzer, dual energy X-ray absorptiometry equipment, skinfold calipers, air displacement plethysmography equipment, and hydrostatic weighing equipment. The bio-impedance analyzer segment accounted for the largest share of the body composition analyzers market in 2020 and is anticipated to grow at a significant rate during the forecast period. This is due to the affordable cost of bio-impedance analyzers, their simplicity, and increased accuracy when compared to other body composition analyzers, in addition to a rise in public awareness of healthy living.
By Product Type
Bio-impedance analyzer segment held a dominant position in 2020 and Skinfold Calipers will maintain the lead over the forecast period.
End User Segment Review
By end user, the market is segmented into hospitals, fitness clubs & wellness centers, and home users. The fitness clubs & wellness centers segment accounted for the majority of the body composition analyzers market share in 2020 and is expected to remain dominant during the forecast period. Rise in health awareness, surge in number of gyms & fitness clubs, and increase in prevalence of obesity across the globe have fueled the growth of the body composition analyzers market. Furthermore, increase in government initiatives to promote healthy lifestyle drives the growth of the market.
By End User
Fitness Clubs & Wellness Centers segment is projected as one of the most lucrative segment.
Region Segment Review
By region, the body composition analyzers market is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to the presence of well-established healthcare infrastructure and continuous R&D initiatives related to the development of body composition analyzers. Furthermore, introduction & adoption of new technologies and high disposable income drive the growth of the market in North America.
By Region
North America was holding a dominant position in 2020 and it will maintain the lead over the analysis period.
This report provides comprehensive competitive analysis and profiles of prominent market players such as Bodystat Ltd., COSMED Srl., General Electric Company (GE Healthcare), Hologic, Inc., Inbody Co., Ltd., Omron Corporation, RJL Systems, Inc., SELVAS AI Inc. (Jawon Medical Co., Ltd.), Seca GmbH & Co.Kg., and Tanita Corporation
Key Benefits for Stakeholders
- This report provides a detailed quantitative analysis of the current body composition analyzers market trends and forecast estimations from 2021 to 2030, which assists to identify the prevailing body composition analyzers market opportunities.
- Market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
- The projections in this report are made by analyzing the current trends and future market potential from 2021 to 2030, in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
- Key market players within the body composition analyzers market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the body composition analyzers market.
Body Composition Analyzers Market Report Highlights
| Aspects | Details |
 By Product Type |
|
 By End User |
|
 By Region |
|
 By Key Players |
|
Analyst Review
In accordance with several interviews conducted, top-level CXOs agree that the utilization of body composition analyzers is anticipated to witness a significant rise with technological advancements and rise in prevalence of obese population. Recent progress and on-going development in this field have fueled the market growth.
According to the CXOs, increase in economic strength of the developing nations, such as Japan, China, India, Indonesia, and Thailand and rise in healthcare expenditure are expected to drive the market during the forecast period.
Rapid growth was observed in the adoption of technologically advanced medical devices across developing economies, and this is expected to offset the challenging conditions in developed markets such as North America and Europe. Moreover, North America and Europe are expected to dominate the market during the forecast period, while emerging countries in Asia-Pacific and Latin America are expected to offer significant growth opportunities during forecast period.
The total market value of Body Composition Analyzers Market is $398.22 million in 2020
The forecast period in the report is from 2021 to 2030
The market value of Body Composition Analyzers Market in 2030 was $618.71 Million
The base year for the report is 2020
Yes, Body Composition Analyzers companies are profiled in the report
The top companies that hold the market share in Body Composition Analyzers Market are Bodystat Ltd., COSMED Srl, General Electric Company (GE Healthcare), Hologic, Inc., Inbody Co., Ltd., Omron Corporation, RJL Systems, Inc., SELVAS AI Inc. (Jawon Medical Co., Ltd.), Seca GmbH & Co.Kg., and Tanita Corporation.
The key trends in the Body Composition Analyzers Market are Developments such as wireless technology and artificial intelligence (AI) in body composition analyzers are anticipated to expand the range of clinical indications.
Loading Table Of Content...
